U.S., March 8 -- ClinicalTrials.gov registry received information related to the study (NCT06863233) titled 'A Study of CD8+ T Cell Imaging During Treatment in People With Non-Small Cell Lung Cancer' on March 03.
Brief Summary: The purpose of this study to learn whether PET/CT (positron emission tomography/computed tomography) scans using an imaging agent (radiotracer) called zirconium Zr 89 crefmirlimab berdoxam is a safe and effective way to identify CD8+ T cells
Study Start Date: March 03
Study Type: INTERVENTIONAL
Condition:
Lung Cancer
Non Small Cell Lung Cancer
Metastatic Non Small Cell Lung Cancer
Intervention:
DRUG: Zirconium Zr 89 crefmirlimab berdoxam
Zirconium Zr 89 crefmirlimab berdoxam, the investigational agent propose...